dual 5-HT 2C receptor activators/5-HT 2A and 2B receptor inhibitors (University of Florida)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedual 5-HT 2C receptor activators/5-HT 2A and 2B receptor inhibitors (University of Florida)
Drug Alias Nametetrahydronaphthalene derivatives (University of Florida)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor agonistsSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 2b (5-HT2b) receptor antagonists
TargetsSerotonin 2b (5-HT2b) receptorSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsMental DisordersCocaine-Related DisordersAmphetamine-Related Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Florida
Active IndicationsN/A
Inactive IndicationsMental DisordersCocaine-Related DisordersAmphetamine-Related Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksN/A